Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at PLN 91.7B, ahead of Biogen (PLN 73.8B) and Amgen (PLN 35B). Figures as of 19 Nov 2026, 22:39 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesPLN 91.7B
Median
PLN 6.5B
Combined market value
PLN 2.97T
Countries
1

Market values as of .

United States
All sectors
Biotech
PLN
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CarePLN 91.7BPLN 834.7BPLN 672.99 1.45% down 35% up United States
2BiogenBIIB · Health CarePLN 73.8BPLN 147.6BPLN 998.71 1.70% down 49% up United States
3AmgenAMGN · Health CarePLN 35BPLN 959.2BPLN 1,773.38 1.14% down 32% up United States
4ModernaMRNA · Health CarePLN 35BPLN 325.9BPLN 805.54 1.29% up 780% up United States
5Neurocrine BiosciencesNBIX · Health CarePLN 13.1BPLN 64.1BPLN 632.82 3.85% down 17% up United States
6VaxcytePCVX · Health CarePLN 10.9BPLN 37.3BPLN 235.85 0.27% down 23% up United States
7ExelixisEXEL · Health CarePLN 8.7BPLN 64.9BPLN 266.04 3.60% down 63% up United States
8Bio-TechneTECH · Health CarePLN 8.5BPLN 46.2BPLN 293.80 0.07% down 24% up United States
9RepligenRGEN · Health CarePLN 8.5BPLN 44BPLN 688.18 1.38% down 12% up United States
10Revolution MedicinesRVMD · Health CarePLN 6.6BPLN 139.4BPLN 644.30 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health CarePLN 6.4BPLN 41.2BPLN 482.48 1.44% down 87% up United States
12Krystal BiotechKRYS · Health CarePLN 4.9BPLN 37.8BPLN 1,276.31 0.15% up 54% up United States
13ImmunovantIMVT · Health CarePLN 3.4BPLN 27.2BPLN 131.42 1.96% down 46% up United States
14CG OncologyCGON · Health CarePLN 3BPLN 29.6BPLN 330.98 2.38% up 97% up United States
15Twist BioscienceTWST · Health CarePLN 1.9BPLN 30.8BPLN 451.08 4.07% down 346% up United States
16Scholar Rock HoldingSRRK · Health CarePLN 992.1MPLN 24.8BPLN 203.56 4.94% up 26% up United States
17Adaptive BiotechnologiesADPT · Health CarePLN 884.2MPLN 18.3BPLN 113.36 1.44% down 74% up United States
18Kodiak SciencesKOD · Health CarePLN 636MPLN 25.9BPLN 395.64 0.09% up 399% up United States
19Halozyme TherapeuticsHALO · Health CarePLN 197.3MPLN 42.9BPLN 376.00 2.88% down 39% up United States
20ImmunityBioIBRX · Health Care-PLN 2BPLN 28.2BPLN 26.55 1.94% down 232% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0412 PLN).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (PLN 91.7B), Biogen (PLN 73.8B) and Amgen (PLN 35B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 19 Nov 2026, 22:39 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of PLN 2.97T as of 19 Nov 2026, 22:39 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.